Global /China /Healthcare /Drug Manufacturers - General /603566

Pulike Biological Engineering, Inc.

603566

• SSE: 603566 • Delayed

11.97CNY -0.3%

1.77 USD

As of 17 June 2026, Pulike Biological Engineering, Inc. has a market cap of $604.42M USD, ranking #13944 globally and #4280 in China. It ranks #1251 in the Healthcare sector, and #464 in the Drug Manufacturers - General industry.

Global Rank

13944

Country Rank

4280

Sector Rank

1251

Industry Rank

464

Key Stats

Market Cap

$604.42MUSD

4.09B CNY

Enterprise Value

$513.9MUSD

3.48B CNY

Revenue (TTM)

$160.95MUSD

1.09B CNY

EBITDA (TTM)

$46.07MUSD

311.78M CNY

Net Income (TTM)

$27.32MUSD

184.99M CNY

EBITDA Margin

29%

Profit Margin

17%

PE Ratio

22.2

Forward PE

17.3

PS Ratio

3.8

PB Ratio

1.5

EV/EBITDA

11.0

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Wei Hu open_in_new

Employees

1,551

Founded

1995

Website

pulike.com.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.3%	-4.3%	-4%	-14%	-15%	-3.4%	-9%	-55%	-45%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	603566 普莱柯生物工程股份有限公司 Class A ISIN: CNE1000025N0 Shares Out.: Shares Outstanding: 341.919M¹ Shares Float: 237.154M² TV: TradingView: SSE: 603566 SA: Stock Analysis: SHA: 603566 YF: Yahoo Finance: 603566.SS GF: Google Finance: SHA: 603566 BA: Barron's: 603566 MS: Morningstar: XSHG: 603566	11.97 CNY	TV: TradingView: SSE: 603566 SA: Stock Analysis: SHA: 603566 YF: Yahoo Finance: 603566.SS GF: Google Finance: SHA: 603566 BA: Barron's: 603566 MS: Morningstar: XSHG: 603566

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Pulike Biological Engineering, Inc.

Pulike Biological Engineering, Inc. engages in the research, development, production, and sale of veterinary biological products, chemical drugs, and traditional Chinese veterinary drugs. The company offers vaccines, antibodies, and medicines for swine and poultry, as well as disinfectants. Pulike Biological Engineering, Inc. was founded in 1995 and is headquartered in Luoyang, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.89B 364.89B CNY 9K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.67B 336.36B CNY 8K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 5K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 3K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.52B 111.89B CNY 3K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 3K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 126K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 90K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 60K%	97.4	United States
Roche Holding AG SIX: RO	$322.73B 256.25B CHF 53K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.3B 215.59B GBP 48K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$275.68B 218.9B CHF 46K%	20.5	Switzerland

chevron_leftBack